文献速递慢性肾脏病急性肾损伤

不确定潜能克隆性造血与CKD肾衰竭风险:东亚队列研究

Clonal Hematopoiesis of Indeterminate Potential and Kidney Failure in CKD: An East Asian Cohort Study.
PubMed 文献 · Clin J Am Soc Nephrol · 2026-06-11

该研究在韩国KNOW-CKD队列175例CKD患者与700例匹配一般人群对照中比较CHIP患病率,并在KNOW-CKD及232例匹配UK Biobank CKD参与者中评估CHIP与肾衰竭风险。结果显示CKD患者CHIP患病率更高(17% vs 11%),CHIP与肾衰竭风险升高独立相关,且在东亚与欧洲队列中一致。

要点

  • CKD患者CHIP患病率高于一般人群(17% vs 11%,P=0.04)。
  • CHIP与CKD患者肾衰竭风险升高独立相关(KNOW-CKD aHR 1.90)。
  • UK Biobank CKD队列中CHIP与肾衰竭关联一致(aHR 2.16)。

核心结论

  • CHIP在CKD患者中更常见,并作为肾衰竭的独立危险因素,该关联在东亚与欧洲队列中一致。

研究设计与样本

  • KNOW-CKD队列175例韩国CKD患者与GENIE队列700例匹配一般人群对照比较CHIP患病率。
  • 在KNOW-CKD队列及232例匹配UK Biobank CKD参与者中,用多变量Cox回归评估CHIP与肾衰竭风险。
  • CHIP定义为驱动突变变异等位基因分数(VAF)≥2.0%,采用深度靶向测序识别。

主要发现

  • KNOW-CKD队列CHIP患病率为17%,GENIE对照为11%(P=0.04)。
  • KNOW-CKD中位随访10.0年,66例(38%)发生肾衰竭;CHIP与肾衰竭风险升高相关(aHR 1.90;95%CI 1.03–3.51)。
  • UK Biobank中位随访12.9年,43例(20%)发生肾衰竭;CHIP与肾衰竭风险升高相关(aHR 2.16;95%CI 1.15–4.03)。
  • CHIP阳性者中,KNOW-CKD队列CHIP相关突变中位VAF为7.3%,GENIE对照为4.4%(P=0.02)。

关键数值与推荐

  • CHIP判定标准为变异等位基因分数(VAF)≥2.0%。

临床怎么用

  • 对CKD患者可关注CHIP作为肾衰竭风险分层的新兴生物标志物,但尚需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: Clonal hematopoiesis of indeterminate potential was more prevalent in patients with CKD than the general population. Clonal hematopoiesis of indeterminate potential was associated with a higher risk of kidney failure in patients with CKD across both the Korean and European ancestry populations. Variant allele fraction of clonal hematopoiesis of indeterminate potential‑associated mutations was higher in patients with CKD than those without CKD. BACKGROUND: Clonal hematopoiesis of indeterminate potential (CHIP) is an age-related condition associated with inflammation. Although CKD shares these pathophysiological features, the prognostic role of CHIP on CKD progression remains unclear, particularly in underrepresented East Asian populations. METHODS: Deep targeted sequencing of CHIP-driving mutations was used to identify the presence of CHIP, defined as variant allele fraction (VAF) ≥2.0%. CHIP prevalence was compared between 175 Korean participants with CKD in the Korean Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD) cohort and 700 matched general population controls in the Gene-Environmental Interaction and Phenotype (GENIE) cohort. The association between CHIP and kidney failure (KF) risk was evaluated using multivariable Cox regression analysis both in the KNOW-CKD cohort and 232 matched UK Biobank participants with CKD. Furthermore, VAF was compared between CHIP-positive participants in the KNOW-CKD and GENIE cohorts. RESULTS: The prevalence of CHIP was significantly higher in the KNOW-CKD cohort than in the GENIE cohort (17% versus 11%; P = 0.04). Over a median follow-up of 10.0 years, 66 participants (38%) developed KF in the KNOW-CKD cohort. After multivariable adjustment, CHIP was associated with higher risk of KF (adjusted hazard ratio, 1.90; 95% confidence interval, 1.03 to 3.51). Furthermore, in the UK Biobank, KF occurred in 43 participants (20%) over a median follow-up of 12.9 years and the association of CHIP with higher risk of KF was consistently observed (adjusted hazard ratio, 2.16; 95% confidence interval, 1.15 to 4.03). Furthermore, among CHIP-positive participants, the median VAF of CHIP-associated mutations was significantly higher in participants within the KNOW-CKD cohort compared with healthy controls in the GENIE cohort (7.3% versus 4.4%; P = 0.02). CONCLUSIONS: CHIP is more prevalent in patients with CKD and serves as an independent risk factor of KF. This association is consistently observed across both an underrepresented East Asian cohort and a European cohort, establishing CHIP as a globally relevant risk factor of CKD progression.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Kim M, An S, Ryu H, et al. Clonal Hematopoiesis of Indeterminate Potential and Kidney Failure in CKD: An East Asian Cohort Study. Clin J Am Soc Nephrol. 2026. PMID: 42275156. doi:10.2215/CJN.0000001092

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。